Literature DB >> 17886151

Identification of feigned mental retardation using the new generation of malingering detection instruments: preliminary findings.

Lili O Graue1, David T R Berry, Jessica A Clark, Myriam J Sollman, Michelle Cardi, Jaclyn Hopkins, Dellynda Werline.   

Abstract

A recent Supreme Court decision--Atkins v. Virginia, 536 U.S. 304 (2002)--prohibiting the execution of mentally retarded (MR) defendants may have raised the attractiveness of feigning this condition in the criminal justice system. Unfortunately, very few published studies have addressed the detection of feigned MR. The present report compared results from tests of intelligence, psychiatric feigning, and neurocognitive faking in a group of 26 mild MR participants (MR) and 25 demographically matched community volunteers asked to feign MR (CVM). Results showed that the CVM suppressed their IQ scores to approximate closely the level of MR participants. WAIS-III and psychiatric malingering measures were relatively ineffective at discriminating feigned from genuine MR. Although neurocognitive malingering tests were more accurate, their reduced specificity in MR participants was of potential concern. Revised cutting scores, set to maintain a Specificity rate of about .95 in MR clients, were identified, although they require cross-validation. Overall, these results suggest that new cutting scores will likely need to be validated to detect feigned MR using current malingering instruments.

Entities:  

Mesh:

Year:  2007        PMID: 17886151     DOI: 10.1080/13854040600932137

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  1 in total

1.  Detection of malingering: psychometric evaluation of the Chinese version of the structured interview of reported symptoms-2.

Authors:  Chang Liu; Zhening Liu; Helen F K Chiu; Tam Wai-Cheong Carl; Huiran Zhang; Peng Wang; Guowei Wu; Tumbewene E Mwansisya; Longlong Cao; Aimin Hu; Yu Wang; Zhimin Xue
Journal:  BMC Psychiatry       Date:  2013-10-09       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.